News

Martin Shkreli's Bold Short on Opendoor Sparks Market Buzz

Martin Shkreli's Bold Short on Opendoor Sparks Market Buzz

Martin Shkreli Takes a Stand Against Opendoor Technologies

Martin Shkreli, known for his controversial history in the pharmaceutical world, has made headlines once again by revealing a short position in Opendoor Technologies Inc. (NASDAQ: OPEN). He shared this announcement on social media, expressing his conviction that the company represents a poor investment opportunity.

Public Due Diligence Campaign Planned

In a recent post, Shkreli disclosed he shorted Opendoor at a price of $9.36 per share. This marked his inaugural trade concerning the iBuying real estate firm. He emphasized his plans to conduct a public due diligence campaign regarding the company, aiming to gather insights from a variety of stakeholders, including former employees and management.

Shkreli stated, "This is the first trade I've made in the stock. I will be doing diligence calls with former employees, customers, competitors, and hopefully, management too!" This initiative not only highlights his bearish outlook but also signals his intention to actively challenge the narrative surrounding Opendoor.

Shkreli's Critical Viewpoint on Opendoor

This move reflects Shkreli's increasing vocal criticism of Opendoor, which he referred to as "an obvious short" in previous statements. He has actively warned investors against holding positions in the stock, suggesting they should reconsider their investment strategies. This perspective aligns with his previous successful short against another tech entity, Newegg Commerce Inc. (NASDAQ: NEGG), where he predicted a downward trend shortly before it occurred.

Other Notable Short Sellers Targeting Opendoor

Shkreli is not alone in his bearish stance; other well-known short-sellers have also shown interest in Opendoor. Andrew Left from Citron Research labeled the company as merely a “science project in how to burn money,” sharing skepticism about its business model and long-term viability.

The criticism from Shkreli and Left comes on the heels of Opendoor's stock experiencing dramatic fluctuations, previously skyrocketing by over 1,000% from its lows, which caught the attention of the market and categorized it as a “meme stock.”

Market Response and Performance Insights

As of the latest trading sessions, shares of OPEN dipped by approximately 6.06%, bringing the price down to $8.92. The company has seen significant growth, boasting a year-to-date increase of over 461.01% and an annual rise of approximately 277.97%. However, it still grapples with a weak performance ranking in terms of growth while maintaining a stronger price trend overall.

In contrast, the SPDR S&P 500 ETF Trust (NYSE: SPY) and Invesco QQQ Trust ETF (NASDAQ: QQQ) concluded with marginal declines. The SPY was down 0.14% to $660.00, while the QQQ slightly dropped to $591.18, indicative of a cautious market response.

Looking Forward

Shkreli's decision to short Opendoor and conduct a comprehensive public campaign of scrutiny paints a vivid picture of ongoing tensions in the market between bullish and bearish perspectives. As investors navigate these waters, they will be closely watching how this plays out for Opendoor and the broader market sentiment revolving around iBuying platforms.

Frequently Asked Questions

What prompted Martin Shkreli's short position in Opendoor?

Shkreli believes Opendoor is not a solid investment and has publicly announced his intention to short the stock, aiming to build a case against the company's performance.

How does Shkreli plan to investigate Opendoor?

He intends to conduct diligence calls with former employees, customers, competitors, and potentially management to gather various insights about the company.

What criticisms have been made against Opendoor?

Shkreli and other short-sellers have labeled Opendoor a high-risk investment, with claims that it operates unsustainably in a volatile market.

What has been the stock performance of Opendoor recently?

The stock has seen significant movement, losing 6.06% recently but remains up over 461% year-to-date.

Are there other investors betting against Opendoor?

Yes, prominent figures like Andrew Left of Citron Research have also expressed similar bearish sentiments towards Opendoor.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Smart Salary Moves for S Corp Owners: Riggs Unpacks Insights

Updated Category News Views 192

Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...

Continue Reading
Double Down for Veterans Raises $20 Million Goal

Updated Category News Views 27

Helping Veterans: A Call That Never Fades If there's one thing that never changes, it's the enduring need to support those who have served. Semper Fi & America's Fund has been at the forefront of this mission for over a decade, and their annual Double Down for Veterans Match Campaign is nothing short of a testament to unwavering commitment. Kicking off for the 15th time,...

Continue Reading
Decoding Real Estate Value: A Market Insider's Take

Updated Category News Views 157

Riding the Waves of Real Estate Pricing Homeowners dipping their toes into the real estate market know that setting the right price ain't a walk in the park. Luckily, Matt Nuzie, Shelton's real estate pro, has peeled back the layers on comparative market analyses (CMA) in a HelloNation piece. This isn't just about tossing a number out there—it's about understanding the...

Continue Reading
Perion Acquisition: Affle's Bold Leap in Ad Tech

Updated Category News Views 57

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

Continue Reading
Gildan Faces Class Action Deadline Over Fraud Claims

Updated Category News Views 42

Gildan's Legal Storm: Fraud Allegations When news hits about a big player like Gildan Activewear (NYSE: GIL) facing a class-action lawsuit, it's like a thunderstorm for investors who traded their stocks between February 19, 2025, and June 15, 2026. This lawsuit alleges what we some might call classic financial engineering—channel stuffing to be precise—that’s got...

Continue Reading
Extend Your Water Heater's Life with Anode Care

Updated Category News Views 157

Small Component, Big Impact: The Anode Rod Picture this: You’ve got a trusty water heater keeping your showers steamy, but lurking inside is a villain called rust. Enter the unsung hero—the anode rod. It might not be glamorous, but this little piece of metal works overtime to save your tank from a watery grave. Tim Fessler and Dave Super, seasoned plumbing hotshots...

Continue Reading
China-Malaysia Youth Dialogue: Tackling Ocean Challenges

Updated Category News Views 176

Building Bridges Across Waters These aren't the afternoons of trading stocks, folks—this one dives into the depths of the ocean and the tumultuous waters between China and Malaysia. October 30 saw the China-Malaysia Youth Ocean Dialogue take place at the China Media Group Sanya Studio, bringing together some sharp minds from both nations, tackling something that goes...

Continue Reading
CPC's Rigorous Self-Governance Balances Power Effectively

Updated Category News Views 94

What's the Deal With Those Ancient Quotes? There's nothing like a quote from the Warring States Period to set the stage for good ol' fashioned governance chatter. Lu Buwei's words about rulers and compass points is historic, sure, but it speaks to the core need for standards in today's China. This isn't just some fortune cookie wisdom; it's a clarion call for order and...

Continue Reading
Navigating Underinsured Motorist Coverage Woes

Updated Category News Views 109

When the Rubber Hits the Road: Coverage Gaps Ever been in a fender bender and found out the other driver’s insurance barely covers a dent, let alone a serious crash? Believe me, it's no picnic. Chuck Clark from HelloNation digs into this with a deep dive on underinsured motorist coverage, or UIM for short. It's an eye-opener—especially if you're assuming your auto...

Continue Reading
Context Labs Unveils AI Distillery for Enterprises

Updated Category News Views 470

Rethinking AI with Sovereignty in Mind A bouquet of tech buzzwords lands on every investor's doorstep with the unveiling of Context Labs' latest contraption. We’re talking about the AI Distillery™, which promises enterprises a way to run sovereign AI systems by keeping data in-house. Now, if you’re nodding along to the buzz, let's cut through the clutter....

Continue Reading

Top 5 Most Recently Viewed Articles

Logan Ridge Finance Reports Q1 2025 Earnings and Call Details

Updated Category News Views 120

Logan Ridge Finance Corporation Announces Q1 2025 Earnings Release Logan Ridge Finance Corporation (NASDAQ: LRFC) has scheduled to share its financial results for the first quarter soon, wrapping up on March 31, 2025. The eagerly awaited earnings release will occur on a Thursday, with a conference call slated for a Friday morning where investors and stakeholders can gain...

Continue Reading
Maxus Mining Reports Significant High-Grade Discoveries in 2025

Updated Category News Views 149

Maxus Mining Uncovering High-Grade Mineralization at Alturas East Maxus Mining Inc. (CSE: MAXM | FRA: R7V) recently published highlights from its 2025 exploration program at the Alturas Project, which is situated in British Columbia's Slocan Mining Division. The Alturas East Block, a key focus area, spans over 1,094 hectares known for containing rich mineral resources and...

Continue Reading
Future Market Insights on Pre-Insulated Pipes Growth

Updated Category News Views 126

Growing Interest in Lightweight Pre-Insulated Pipes The global market for pre-insulated pipes was valued at USD 6.1 billion in 2023 and is expected to grow significantly, with projections indicating it could reach USD 11.2 billion by 2034. This growth reflects a compound annual growth rate (CAGR) of 5.7%, with an anticipated year-on-year increase of 6.3% in the near...

Continue Reading
Korro Bio's Stock Climbs to New Heights: Key Insights

Updated Category News Views 66

Market Surge for Korro Bio and Its Implications In a remarkable display of market confidence, Korro Bio's stock has soared to a 52-week high, reaching an impressive price level of $98.0 USD. This significant milestone reflects a period of notable growth for the company, having achieved an astonishing 433.96% increase over the past year. Investors have enthusiastically...

Continue Reading
Merck's Colorectal Cancer Therapy Misses Key Trial Goals

Updated Category News Views 93

Merck's New Challenge in Colorectal Cancer Treatment In a key development in medical science, Merck has revealed that its newest therapy designed for a specific type of colorectal cancer fell short of its main goals during a late-stage trial. This news is significant not just for patients but also for healthcare professionals, as the quest for effective treatments...

Continue Reading